Device Trial Radar · NCT04875442
Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
Last checked: Nov 20, 2026Latest source record: Oct 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Oct 30, 2023
Primary completion
Dec 30, 2026
Study completion Dec 30, 2026
Sponsor
- Lead sponsor
- BioSerenityNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 6, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety and performance study of the MemoWave electroencephalographic and sound recording device to increase slow brain waves during sleep to improve memory consolidation in subjects with mild cognitive impairment
Conditions
- Sleep Disorder
Interventions
Memowave emitting soundsDevice
Memowave is worn during one night and emits sounds to increase slow brain waves
Memowave not emitting soundsDevice
Memowave is worn during one night and doesn't emit sounds
Primary outcomes
What the sponsor says the trial is designed to measure.
- accuracy of Electroencephalography signals of MemowaveTime frame: 3 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ICM
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.